STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
25 hedge funds and large institutions have $1.22M invested in Statera Biopharma, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
25
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$22K | |
| 2 | +$18K | |
| 3 | +$2.86K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$938 |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$264 |
Top Sellers
| 1 | -$18K | |
| 2 | -$12K | |
| 3 | -$11K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8K |
| 5 |
VCAM
Van Cleef Asset Management
Beachwood,
Ohio
|
-$5K |